Compound Radar

McKesson Corporation (MCK) Stock Analysis

United States · Healthcare / Medical Distribution

Price $889.12
Market cap $103.66B
Next earnings Nov 4, 2026
Entry status Watch $786.65–$835.31

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

63
63/100 Good Quality
  • Financial Health 65
  • Profitability 45
  • Business Quality 65
  • Balance Sheet 65
  • Cash Flow 80

Why this rating?

Health 63/100 — Good Quality

Strongest Cash Flow 80/100
Softest Profitability 45/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

McKesson Corporation (MCK) is a Medical Distribution company in the Healthcare sector. Compound Radar rates McKesson Corporation 63/100 (Good Quality) due to solid business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 23.82
  • Forward P/E 17.62
  • PEG 1.71
  • EV/Revenue 0.28

Profitability

  • Revenue Growth 7.7%
  • Gross Margin 3.6%
  • Operating Margin 1.3%
  • Net Margin 1.1%

Financial strength

  • Cash $5.16B
  • Debt $11.80B
  • Net Cash $-6.63B
  • Free Cash Flow $5.41B
  • Current Ratio 0.89

Similar companies

Peers in Medical Distribution, ranked by Financial Health.

View all in Medical Distribution →

FAQ

How Compound Radar scores and tracks McKesson Corporation (MCK).

View Methodology & FAQ →